Translational neuroscience workshop on gene therapy hosted by Society for Neuroscience
Shared by Sylvie Raver, PhD | Training & Policy Manager, Society for Neuroscience
Join workshop organizers Florian Eichler and Xandra Breakefield to learn about the breadth of current and emerging gene therapy approaches to treat neurologic disorders such as ALS, muscular dystrophy and brain tumors. Workshop faculty will cover innovative strategies for gene replacement or correction using methods such as CRISPR/Cas; viral vectors; oligonucleotides for inhibition or corrective splicing of disease-causing mRNAs; re-introduction of the patient’s own cells with a corrected genotype; and “armed” cells or viruses to combat brain tumors.
SfN’s Neurobiology of Disease Workshop will include a patient presentation, lectures and small-group breakout discussions with faculty and other attendees, a course syllabus, breakfast and lunch.
NDW registration is open to all SfN members and nonmembers at all career stages. Registrants can secure their workshop spots by adding the workshop to their 2017 annual meeting registration, or can register for the workshop alone without attending the rest of the annual meeting.
Workshop faculty: Xandra Breakefield, Ph.D.; Florian Eichler, M.D.; Charlotte Sumner, M.D.; Robert Brown, M.D., Ph.D.; Martin Ingelsson, M.D., Ph.D.; Karen Aboody, M.D.; Jeff Chamberlain, Ph.D.; Paola Grandi, Ph.D.; David Corey, Ph.D.; Eloise Hudry, Ph.D.; Miguel Sena-Esteves, Ph.D.
Please contact email@example.com with any questions about the workshop.